Form 4: National Health Investors Inc. Executive Acquires Shares and Stock Options

Kevin Carlton Pascoe, Chief Investment Officer of National Health Investors Inc., reports acquisition of common stock and stock options.

Summary

• On February 23, 2024, Kevin Carlton Pascoe, the Chief Investment Officer of National Health Investors Inc. (NHI), acquired 3,000 shares of common stock.
• These shares were acquired at a price of $0, and are restricted stock which vest 20% on each anniversary of the date of grant, starting February 23, 2025.
• Following the transaction, Pascoe directly owns 39,893 shares of common stock.
• Pascoe also acquired stock options to purchase 8,500 shares of common stock at an exercise price of $57.76, exercisable starting February 23, 2024, and expiring on February 23, 2029.
• Additionally, Pascoe acquired stock options to purchase 8,500 shares of common stock at an exercise price of $57.76, exercisable starting February 23, 2025, and expiring on February 23, 2029.
• Pascoe continues to hold various other stock options granted in previous years with exercise prices ranging from $53.41 to $90.79 and expiration dates between 2025 and 2028.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity. The acquisition of shares could be seen as a positive signal, but it's not definitive.

Positives

• The acquisition of shares by a high-ranking officer could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the investment behavior of company executives and directors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of management's confidence in the company.

Key Dates